'Vaccines market' diaporamas de présentation

Adult Vaccines Market & Forecast

450 views • 21 slides

Veterinary Vaccines Market to Grow at a CAGR of 6.9% through 2026

Demand for veterinary vaccines is witnessing an increase, as focus shifts from cure to prevention among farm- and pet- owners. The global pet humanisation trend is massively influencing demand for veterinary healthy products and services, and vaccines are riding on the coattails of this trend. The global veterinary vaccines market is anticipated to reach US$ 7.24 Bn in 2016, up from US$ 6.82 Bn in 2015.

268 views • 12 slides

Global Sales of Dengue Vaccines to Remain Largely Concentrated in Asia-Pacific, 2027

162 views • 9 slides

Vaccines Market to grow at 9% CAGR from 2017 to 2024

Get more details @ http://bit.ly/2zKasVN Some of the major players in vaccines market are AstraZeneca, Abbott, Bristol-Myers Squibb, Merck & Co., Johnson & Johnson, Sanofi Pasteur, Pfizer, GlaxoSmithKline, Emergent BioSolutions, Novartis, Astellas Pharma, CSL and Novavax.

131 views • 9 slides

Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encep

Bharat Book Presents"Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth" provides an in-depth analysis of the travel vaccines, as well as insights into the Travel Vaccines R&D pipeline.

204 views • 7 slides

Global Potential Analysis of Ebola drug and Vaccines Market

To Get Details: http://www.bigmarketresearch.com/ebola-therapeutics-vaccines-market "Global Potential Analysis of Ebola drug and Vaccines Market (Pipeline analysis, Drugs, Vaccines, and Geography) through 2020" Ebola virus disease (EVD), also known as Ebola hemorrhagic fever (EHF), results from Ebola virus and three other closely related viruses in the genes (group of related viruses) of ebola virus. Initial symptoms of this disease include sore throat, headaches, fever and muscles pain. It causes hemorrhagic fever that leads to internal or external bleeding. EVD is widely prevalent in Central and Western Africa, and near tropical rainforests. Due to high mortality rate and unavailability of effective treatments, the pharmaceutical companies have big opportunities to explore.

276 views • 7 slides

Vaccines Market: Industry Report, Analysis 2014-2020

Vaccine is a preparation of weak or killed pathogen to stimulate the immunity process of the body. The vaccine market is a segment under the pediatric drugs market, which accounts to 80% of the pharmaceutical drugs market. The demand for pediatric vaccines is the major driving force of the market. Get access to detailed report at: https://www.alliedmarketresearch.com/vaccines-market

229 views • 7 slides

Vaccines Market worth 48.03 Billion USD by 2021 - Market Dynamics - Key Players Strategies

The global vaccines market is expected to reach 48.03 Billion by 2021 from USD 32.24 Billion in 2016 at a CAGR of 8.3%. The global market is broadly classified into technology, type, disease indication, end-users, and regions.

315 views • 7 slides

Vaccines Market by Technology, Disease Indication, End User & Type - 2021 | MarketsandMarkets

The global vaccines market is expected to reach 48.03 Billion by 2021 from USD 32.24 Billion in 2016 at a CAGR of 8.3%. The global market is broadly classified into technology, type, disease indication, end-users, and regions.

206 views • 7 slides

adult and adolescent vaccines market to 2017

By 2017, the Global Vaccines Market is Expected to Generate More than Twice the Annual Revenue of 2010

499 views • 6 slides

World Ebola drugs and vaccines Market Demand and Forecast 2020

Ebola virus disease (EVD), also known as Ebola hemorrhagic fever (EHF), results from Ebola virus and three other closely related viruses in the genes (group of related viruses) of ebola virus. Request Report Form Available @ http://www.bigmarketresearch.com/report-enquiry/132567

289 views • 6 slides

Global Sheep and Goat Pox Vaccines Market 2015 Industry Insights, Study, Forecasts, Outlook, Development, Growth, Overvi

The report titled Swine Influenza Vaccines provides valuable insights into the factors driving and restraining the global Swine Influenza Vaccines market Research 2015. The report is prepared with the intent of providing an executive-level snapshot of the present dynamics of the global Swine Influenza Vaccines market, and how the same will likely impac

213 views • 6 slides

Global Swine Influenza Vaccines Market 2015 Industry Analysis, Forecasts, Study, Research, Outlook, Shares, Insights and

360 views • 6 slides

Global Theileriosis Vaccines Market 2015 Industry Analysis, Research, Growth, Trends and Overview

for the quality services for mobile development at lowest price in India. www.visainfoworld.com'E-mail Marketing Company in Noida India42295236_ITservicesinnoidaindia-visainfoworldcom.pptx
4public0| 22 |0
??VVrecast the opportunities and developments for the Global VoLTE market in near future. The research report examines the Global VoLTE market by highlighting the definitions, classifications, different applicatio

160 views • 6 slides

Global Hepatitis B Vaccines Market 2015 Industry Growth, Trends, Development, Research and Analysis

The research report on the worldwide Hepatitis B Vaccines market presents a comprehensive analysis of the market and provides statistical data as well as crucial information about it. The report offers an analytical study of the Hepatitis B Vaccines market, taking growth drivers, restraints, and future prospects into consideration. The prevalent trends and opportunities have also been discussed in this study.

193 views • 6 slides

Global Vaccines Market to witness growth of 9% CAGR from 2017 to 2024

Get more details @ http://bit.ly/2zKasVN Some of the major players in vaccines market are AstraZeneca, Abbott, Bristol-Myers Squibb, Merck & Co., Johnson & Johnson, Sanofi Pasteur, Pfizer, GlaxoSmithKline, Emergent BioSolutions, Novartis, Astellas Pharma, CSL and Novavax.

92 views • 6 slides

R&I: Potential Analysis of Ebola drug & Vaccines Market 2020

Ebola virus disease (EVD), also known as Ebola hemorrhagic fever (EHF), results from Ebola virus and three other closely related viruses in the genes (group of related viruses) of ebola virus. The report provides in-depth coverage of the ebola therapeutics and vaccines market including drivers, restraints and opportunities would help professionals to better understand market behavior. Detailed report at: http://www.reportsandintelligence.com/ebola-therapeutics-vaccines-market

264 views • 5 slides

The global vaccines market is expected to reach 48.03 Billion by 2021

Vaccines Market report categorizes the Global Market by Disease Indication (HPV, Pneumococcal, Influenza, Hepatitis, Rotavirus, DTP, Polio, MMR), Technology (Inactivated & Subunit, Recombinant, Live Attenuated, Toxoid, Conjugate), End User (Pediatrics, Adults), Type & Geography

129 views • 3 slides

Veterinary/Animal Vaccines Market worth 7.68 Billion USD by 2021

Veterinary/Animal Vaccines Market report categorizes the global market by Product (Porcine, (Companion-Canine), (Livestock-Bovine), Poultry, Aquaculture), Diseases (Rabies, FMD, Swine Influenza, Strangles, Furunculous), Technology (DNA, Recombinant, Inactivated, Conjugate) & Geography

125 views • 3 slides

Veterinary Vaccines Market Research Report Forecast to 2024

According to the research report, the global veterinary vaccines market, which held an opportunity worth US$6.27 bn in 2015, will exhibit a healthy 6.9% CAGR from 2016 through 2024, and rise to a valuation of US$11.40 bn by 2024.

116 views • 3 slides